Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-11
2010-02-02
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S249000
Reexamination Certificate
active
07655654
ABSTRACT:
This invention comprises the novel compounds of formula (I)wherein r, s, t, R1, R2, R3, R4, R5, and R6have defined meanings, having farnesyl transferase inhibiting activity; their preparation, compositions containing them and their use as a medicine.
REFERENCES:
patent: 6187786 (2001-02-01), Venet et al.
patent: 6458800 (2002-10-01), Angibaud et al.
patent: 6914066 (2005-07-01), Angibaud et al.
patent: 2002/0049327 (2002-04-01), Venet et al.
patent: 0371564 (1990-06-01), None
patent: 0371564 (1990-06-01), None
patent: WO 97/16443 (1997-05-01), None
patent: WO 97/21701 (1997-06-01), None
patent: WO 98/40383 (1998-09-01), None
patent: WO 98/49157 (1998-11-01), None
patent: WO 98/55124 (1998-12-01), None
patent: WO 00/01386 (2000-01-01), None
patent: WO 00/01411 (2000-01-01), None
patent: WO 00/12498 (2000-03-01), None
patent: WO 00/12499 (2000-03-01), None
patent: WO 00/39082 (2000-07-01), None
patent: WO 00/47574 (2000-08-01), None
patent: WO 01/53289 (2001-07-01), None
patent: WO 01/98302 (2001-12-01), None
patent: WO 02/24682 (2002-03-01), None
patent: WO 02/24683 (2002-03-01), None
patent: WO 02/24686 (2002-03-01), None
patent: WO 02/24687 (2002-03-01), None
International Search Report mailed Aug. 5, 2003 for PCT/EP 03/03986.
Kohl, et al., “Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor”, Science, 1993, vol. 260, 1934-1937.
Oertel, F., “Zur Synthese von ‘1, 2, 3, 4!tetrazolo’ 1, 5-a!-und 1, 5-b!chinazolinen” Pharmazie, 1990, vol. 45 No. 5, p. 370.
Rak, J., et al., “Mutant ras Oncogenes Upregulate VEGF/VPF Expression: Implications for Induction and Inhibition of Tumor Angiogenses1”, Cancer Research, 1995, 55(20), 4575-80.
Angibaud Patrick Rene
Argoullon Jean Michel Jacques Raymond
Venet Marc Gaston
Janssen Pharmaceutica NV
Ward Paul V.
Wilson James O.
LandOfFree
Farnesyl transferase inhibiting tricyclic quinazoline... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Farnesyl transferase inhibiting tricyclic quinazoline..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesyl transferase inhibiting tricyclic quinazoline... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153709